Fate Therapeutics Inc

Vanguard Personalized Indexing Management, LLC FATE

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

50,947

Value ($000)

50

Weight

0.0%

2021 Q2 - 2025 Q4 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	50	0.0%	50,947	12/31/2025
2025 Q3	10/31/2025	81	0.0%	64,243	9/30/2025
2025 Q2	7/25/2025	80	0.0%	71,364	6/30/2025
2025 Q1	5/14/2025	34	0.0%	43,096	3/31/2025
2024 Q4	2/10/2025	24	0.0%	14,772	12/31/2024
2024 Q3	11/12/2024	49	0.0%	13,951	9/30/2024
2024 Q2	8/12/2024	48	0.0%	14,777	6/30/2024
2024 Q1	5/9/2024	100	0.0%	13,582	3/31/2024
2023 Q4	2/8/2024	46	0.0%	12,357	12/31/2023
2023 Q3	11/8/2023	30	0.0%	14,354	9/30/2023
2022 Q2	8/12/2022	250	0.0%	10,100	6/30/2022
2022 Q1	5/16/2022	405	0.0%	10,434	3/31/2022
2021 Q4	2/23/2022	236	0.0%	4,032	12/31/2021
2021 Q3	11/9/2021	226	0.0%	3,807	9/30/2021
2021 Q2	8/11/2021	215	0.0%	2,481	6/30/2021